Target intelligence / Profile preview

Mycobacterial membrane lipid bilayer

Molecular classification
Lipid bilayer, Cell envelope component, Other
01

Overview

The mycobacterial membrane lipid bilayer is a fundamental structural component of the mycobacterial cell envelope, distinguished by its exceptional complexity and high lipid content (Brennan & Nikaido, 1995). It consists of an inner cytoplasmic membrane and a unique outer membrane, known as the mycomembrane, which is primarily composed of long-chain mycolic acids (Dulberger et al., 2020). This lipid-rich architecture functions as a highly effective permeability barrier, shielding the bacterium from host immune responses and limiting the entry of many conventional antibiotics (Minnikin, 1982). In the context of disease, this barrier is a primary reason for the intrinsic drug resistance observed in Mycobacterium tuberculosis and other mycobacterial pathogens (Dulberger et al., 2020). Therapeutic strategies often target the membrane by inhibiting the biosynthesis of its lipid constituents, such as mycolic acids, or by directly disrupting membrane integrity and the proton motive force (Zhang et al., 2003). Additionally, membrane-bound proteins like ATP synthase are the targets of modern antitubercular drugs like bedaquiline (Andries et al., 2005). Understanding the complex architecture of this lipid bilayer is crucial for developing new treatments against drug-resistant mycobacterial strains.

Other names
Mycobacterial cell envelopeMycomembraneMycobacterial plasma membraneMycobacterial outer membraneMycobacterial cell membrane
02

Mechanism of action

Inhibition of mycolic acid biosynthesis, disruption of the proton motive force and membrane potential, inhibition of membrane-bound ATP synthase, and disruption of membrane physical integrity.

03

Biological functions

Permeability barrierEnergy transductionStructural integrityProtection from host immune responseNutrient transportCell division
04

Disease associations

TuberculosisLeprosyNontuberculous mycobacterial infectionInfection
05

Safety considerations

Development of multi-drug resistance (MDR-TB)Hepatotoxicity associated with drugs targeting membrane synthesisPoor drug penetration due to the hydrophobic nature of the bilayerPotential off-target effects on host mitochondrial membranes
06

Interacting drugs

Pyrazinamide

7 more in the full profile.

07

Biomarkers

Lipoarabinomannan (LAM)

Beyond the preview

Go deeper on Mycobacterial membrane lipid bilayer.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Mycobacterial membrane lipid bilayer.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call